Document is current
Any future updates will be listed below
-
Authors
Ichiba, Tomohisa
Suzuki, Masahiro
Aritake-Okada, Sayaka
Uchiyama, Makoto
- License Information
-
More Information
Article History
Received: 3 August 2020
Accepted: 6 November 2020
First Online: 23 November 2020
Competing interests
: Dr. M. Uchiyama has received research support from Astellas Pharma, Eisai, Meiji Seika Pharma, MSD, Taisho Pharmaceutical, Kao Corporation, and Takeda Pharmaceutical, and　has consulted for Kao Corporation, Taisho Pharmaceutical and Takeda Pharmaceutical. He has also received honoraria for giving lectures and/or contributing text from Eisai, Meiji Seika Pharma, MSD, and Takeda Pharmaceutical. Dr. M. Suzuki has received research support from Novartis and Otsuka Pharmaceutical, and has received honoraria for giving lectures from Dainippon Sumitomo, Eisai, Meiji Seika Pharma, MSD, Otsuka Pharmaceutical and Takeda Pharmaceutical. Dr. M. Suzuki has received research support from Novartis and Otsuka Pharmaceutical, and has received honoraria for giving lectures from Dainippon Sumitomo, Eisai, Meiji Seika Pharma, MSD, Otsuka Pharmaceutical and Takeda Pharmaceutical. T. Ichiba is an employee of Kao Corporation. Dr. S. Aritake-Okada declares no potential conflict of interest.
